Line 420: |
Line 420: |
| |[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] | | |[[GTS5:Neurofibromatosis_type_1_(NF1)|Neurofibromatosis type 1 (NF1)]] |
| |Disease | | |Disease |
| + | |Ngoni Faya (trainee) + Madina Sukhanova |
| + | |7/12/2023 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Madina Sukhanova (Madina S) |
| | | | | |
− | | | + | |Named based on GTS5 book |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] | | |[[GTS5:NF2-related_schwannomatosis_(NF2)|NF2-related schwannomatosis (NF2)]] |
Line 497: |
Line 497: |
| |[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] | | |[[GTS5:Familial_adenomatous_polyposis_(APC)|Familial adenomatous polyposis (APC)]] |
| |Disease | | |Disease |
| + | |Jennifer Laffin |
| + | |8/20/2023 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |MS / LS |
| | | | | |
− | | | + | |Named based on GTS5 book |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] | | |[[GTS5:Gastric_Adenocarcinoma_and_Proximal_Polyposis_of_Stomach_-_GAPPS_(APC_promoter)|Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] |
Line 581: |
Line 581: |
| | | | | |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
| |- | | |- |
| |[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | | |[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] |
Line 592: |
Line 592: |
| | | | | |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
| |- | | |- |
| |[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | | |[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] |
Line 841: |
Line 841: |
| | | | | |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
| |- | | |- |
| |[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] | | |[[GTS5:Retinoblastoma_syndrome_(RB1)|Retinoblastoma syndrome (RB1)]] |
Line 942: |
Line 942: |
| |[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] | | |[[GTS5:Constitutional_mismatch_repair_deficiency_(CMMRD)_syndrome_(MLH1,_PMS2,_MSH2,_MSH6)|Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] |
| |Disease | | |Disease |
| + | |Jennie Thurston |
| + | |7/2/2023 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
− | | | + | |Named based on GTS5 book |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] | | |[[GTS5:BRCA-related_cancer_predisposition_syndrome_(BRCA1,_BRCA2)|BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] |
| |Disease | | |Disease |
| + | |Constance Albarracin / Katherine Geiersbach |
| | | | | |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] | | |[[GTS5:PALB2-related_cancer_predisposition_syndrome_(PALB2)|PALB2-related cancer predisposition syndrome (PALB2)]] |
| |Disease | | |Disease |
| + | |Constance Albarracin / Katherine Geiersbach / Jun Liao |
| | | | | |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] | | |[[GTS5:RAD51-related_cancer_predisposition_syndrome_(RAD51C,_RAD51D)|RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] |
Line 1,041: |
Line 1,041: |
| |[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] | | |[[GTS5:Ataxia-telangiectasia_syndrome_(ATM)|Ataxia-telangiectasia syndrome (ATM)]] |
| |Disease | | |Disease |
| + | |Evin Gulbahce / Katherine Geiersbach |
| | | | | |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |Katherine Geiersbach |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] | | |[[GTS5:CHEK2-related_hereditary_(breast)_cancer_predisposition_syndrome_(CHEK2)|CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] |
Line 1,059: |
Line 1,059: |
| | | | | |
| | | | | |
− | | | + | |Named based on GTS5 book (page created 12/30/23) |
| |- | | |- |
| |[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] | | |[[GTS5:Nijmegen_breakage_syndrome_(NBN)|Nijmegen breakage syndrome (NBN)]] |
Line 1,321: |
Line 1,321: |
| |[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] | | |[[GTS5:DICER1-related_tumour_predisposition_syndrome_(DICER1)|DICER1-related tumour predisposition syndrome (DICER1)]] |
| |Disease | | |Disease |
| + | |Jennie Thurston |
| + | |7/2/2023 |
| | | | | |
| + | |PENDING |
| | | | | |
| + | |LS |
| | | | | |
− | | | + | |Named based on GTS5 book |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
| |[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] | | |[[GTS5:MicroRNA_processor_tumour_predisposition_syndromes_(DROSHA,_DGCR8)|MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] |